Endosomal sorting complexes required for transport (ESCRTs) mediate sorting of ubiquitinated membrane proteins into multivesicular bodies en route to lysosomes for degradation. A mutation in CHMP2B (CHMP2B Intron5 , an ESCRT-III component) that is associated with a hereditary form of frontotemporal dementia (FTD3) disrupts the endosomal-lysosomal pathway and causes accumulation of autophagosomes and multilamellar structures. We previously demonstrated that expression of CHMP2B Intron5 in the Drosophila eye using GMR-Gal4 causes misregulation of the Toll receptor pathway. Here, we show that ectopic expression of CHMP2B Intron5 using eyeless-Gal4 (ey> CHMP2B Intron5 ), a driver with different spatiotemporal expression attributes than GMR-Gal4 in the Drosophila eye, causes eye deformities when compared to expression of wild-type CHMP2B (CHMP2B WT ) and the Drosophila homologue of CHMP2B (CG4618). In addition, ey>CHMP2B
Eukaryotic cells degrade transmembrane proteins and receptors within lysosomes via a process that involves sorting of ubiquitinated transmembrane proteins into multivesicular bodies (MVBs), which then fuse with the lysosomes to degrade the cargo (1-3). The endosomal sorting complex required for transport (ESCRT) machinery, which primarily consists of 4 heteromeric subcomplexes (ESCRT-0, -I, -II, and -III), mediates MVB biogenesis through cargo sorting and endosomal membrane remodeling (1, 2) . Recycling of cell surface receptors via MVBs allows homeostasis of receptors and their signaling pathways. In addition to MVB formation, ESCRTs are involved in macroautophagy, epithelial cell polarity, cell migration, cytokinesis, dendritic spine morphogenesis, and viral budding (2) . Consequently, disruption of ESCRT function is associated with a number of diseases, including cancer, pathogenic infections, and neurodegenerative diseases, such as frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), Huntington's disease, paraparesis, and prion disease (2, 4, 5) .
Mutations in CHMP2B (vps2 in yeast and CG4618 in Drosophila), an ESCRT-III subunit, are associated with familial cases of FTD linked to chromosome 3 (6) and ALS (7) (8) (9) . One of the CHMP2B mutations in the splice acceptor site for the sixth exon (CHMP2B Intron5 ), which was originally identified in a Danish family with FTD3, results in truncation of 35 aa at the carboxyl terminus of the protein (6, 10) . Multiple cellular and physiological defects of CHMP2B
Intron5 have been observed in primary neurons, cell lines, Drosophila, and mice, including impaired endosomal-lysosomal fusion, accumulation of autophagosomes and ubiquitin-and p62-positive inclusions, morphological defects in dendritic arbor and spines and axonal swelling, and receptor misregulation (11) (12) (13) (14) (15) (16) (17) (18) . It has been proposed that CHMP2B
Intron5
-mediated defects have a gain-of-function effect, since overexpression of CHMP2B
WT in mice and flies or CHMP2B-knockout mice results in either mild or no phenotypes (11, 14, 15) .
Ectopic expression of CHMP2B Intron5 in the Drosophila eye by GMR-Gal4 misregulates Toll receptor and its signaling pathway (11) . Since receptor expression and activity are spatiotemporally regulated, we investigated whether CHMP2B
Intron5 -mediated disruption of ESCRT function during different stages of eye development will result in differential receptor misregulation and therefore different phenotypes. To accomplish this, we used the ey-Gal4 driver of the Gal4-upstrean activating sequence (UAS) expression system, which enables spatiotemporal control of transgene expression (19) . ey-Gal4 expression is initiated during the embryonic stage and continues later in larva in all cells of the eye disc preceding the morphogenetic furrow, which is formed by a series of events defining the specification of Drosophila photoreceptor cell fate determination and differentiation (20, 21) . GMR-Gal4 expression is initiated later than ey-Gal4 during eye development in cells posterior to the morphogenetic furrow (22, 23) . Here, ey-Gal4 driven expression of UAS-Flag-CHMP2B

(eyϾCHMP2B
Intron5 ) was used to examine the effects of dysfunctional ESCRT-III caused by CHMP2B
Intron5 in the regulation of Notch signaling during eye morphogenesis.
MATERIALS AND METHODS
Fly stocks
UAS-Flag-CHMP2B
Intron5 transgenic flies were generated by including an N-terminal Flag tag using the previously described cloning and transgenic techniques (11, 15) . To generate UAS-CG4618 flies, cDNA (LD36173; Drosophila Genomics Resource Center, Indiana University, Bloomington, IN, USA) was cloned into pUAST vector, which was followed by sequencing and microinjection into w 1118 flies to obtain the transgenic line. The primers used for cloning into pUAST vector were as follows: CG4618, 5=-GCGGCCGCGAT-GTTCAACAATA-3= and 5=-TCTAGACTAAGAGGAGCGCAG-3=. Canton-S (CS), eyeless-Gal4 (ey-Gal4), and Notch (N 264-39 ) Drosophila stocks were obtained from the Bloomington Stock Center (Bloomington, IN, USA). Flies were reared on a yeast-supplemented cornmeal-based diet (Nutri-Fly Bloomington Formula, Genesee Scientific, San Diego, CA, USA) and kept at 25°C under a 12-h light-dark cycle. CS was used as the wild-type control. ey-Gal4 flies were recombined with UAS-Flag-CHMP2B
Intron5 flies.
Phenotype range quantification and eclosion assay
The eye phenotype was quantified by assigning each fly (100 flies/genotype) to one of the following categories: normal shape and size, small/ablated, enlarged with approximately normal shape, and deformed and enlarged. To determine the eclosion percentages, flies of the appropriate genotype were placed in an embryo collection chamber. Next, 100 embryos in 4 batches of 25 embryos were transferred to a vial containing food, and the numbers of adults emerging in each vial were counted. One-way ANOVA with the post hoc Scheffé test was used to identify significant differences (PϽ0.05) among genotypes.
Western blotting
Adult fly heads of the appropriate genotype were homogenized in RIPA buffer (Thermo Scientific, Pittsburgh, PA, USA), after which Western blots were performed following standard procedures. The gels were then transferred to PVDF membranes, which were later detected and scanned using GelDoc (Bio-Rad, Hercules, CA, USA). Specifically, 1:1000 dilutions of anti-CHMP2B (a gift from F.-B.G.), anti-rhodopsin [4C5; Developmental Studies Hybridoma Bank (DSHB), University of Iowa, Iowa City, IA, USA], anti-tubulin (E7; DSHB), anti-Notch (C17.9C6, DSHB), anti-Numb (Santa Cruz Biotechnology, Dallas, TX, USA), and anti-Flag (SigmaAldrich, St. Louis, MO, USA) primary antibodies produced in mice were used to probe for Rh1 rhodopsin, tubulin, and Flag-CHMP2B Intron5 , respectively. In addition, 1:1000 dilutions of HRP-goat anti-mouse (Santa Cruz Biotechnology), HRP-goat anti-rabbit (Santa Cruz Biotechnology), and HRPdonkey anti-goat (Santa Cruz Biotechnology) were used as the secondary antibody. The data presented are based on three independent replicates.
Histology
Cryosectioning and immunohistochemistry were performed as described previously, with minor modifications (24) . Briefly, 12-m cryosections of adult fly heads embedded in TissueTek optimal cutting temperature (OCT) compound (Ted Pella, Redding, CA, USA) were probed with 1:50 anti-Rh1 rhodopsin (4C5), anti-Notch (C17.9C6), anti-Rab5 (a gift from F.-B.G.), and Rab7 (a gift from F.-B.G.) and 1:50 dilutions of Alexa Fluor 488 anti-rabbit (Invitrogen, Grand Island, NY, USA), and Alexa Fluor 568 anti-mouse (Invitrogen) were used as secondary antibodies. The slides from 3 independent replicates were then mounted with Fluoro Gel II with DAPI (Electron Microscopy Sciences, Hatfield, PA, USA) and imaged using an AxioCam MRm camera on an Imager A2 fluorescent microscope (Zeiss, Thornwood, NY, USA).
Adult phototactic assay
An adult phototactic assay was conducted according to a previously described countercurrent distribution method with minor modifications (25) . Briefly, the phototactic apparatus consisted of two polypropylene narrow fly vials (Genesee Scientific) lined with black electrical tape inside and out, except for the bottom of one vial, and a 20-W electric bulb was positioned immediately above the vial at the clear end. Adult flies (25) (26) (27) (28) (29) (30) were acclimated to the apparatus for 10 min, after which they were subjected to 3 trials to measure whether they selected the light or dark end of the apparatus. Oneminute rests were provided between trials. Independent replicates (3-5) consisted of previously untested flies. One-way ANOVA with a post hoc Scheffé test was used to identify significant differences (PϽ0.05) among genotypes.
Real-time polymerase chain reaction (PCR)
Total RNA (with DNase treatment) from 10 -15 adult fly heads of the appropriate genotype was isolated using an RNeasy miniprep kit (Qiagen, Valencia, CA, USA). RNA quality and yield were then measured using a Nanodrop spectrometer (Thermo Scientific). Quantitative reverse transcription PCR (qRT-PCR) was performed in duplicate with 50 -100 ng total RNA using a 1-step Quantifast SYBR Green RT-PCR kit (Qiagen) and a StepONE Real-Time PCR system (Applied Biosystems, Grand Island, NY, USA). The relative normalized transcript level was determined by the ⌬⌬C t method based on 3 independent replicates. RP49 was used as the normalizing gene. The primers used for qRT-PCR were as follows: enhanced green fluorescent protein (eGFP), 5=-AGTC-CGCCCTGAGCAAAGA-3= and 5=-TCCAGCAGGACCATGTGA-TC-3=; RP49, 5=-CGGTTACGGATCGAACAAGC-3= and 5=-CT-TGCGCTTCTTGGAGGAGA-3=.
RESULTS
ey>CHMP2B
Intron5 flies exhibit eye deformities and a phototactic defect
To identify the effects of CHMP2B
Intron5 expression, we used ey-Gal4 to express UAS-Flag-CHMP2B Intron5 (eyϾ CHMP2B Intron5 ) during early eye specification and morphogenesis in flies. In contrast to wild-type (Fig. 1A, 
A=), eyϾCHMP2B
Intron5 flies showed severe defects in eye morphology, including enlargement, rippling, protuberances, and reduction/ablation, whereas ey-Gal4 and UAS-CHMP2B
Intron5 eyes appeared like wild-type eyes (Fig. 1B-D= and Supplemental Fig. S1 ). The enlarged and deformed eye phenotypes were observed more frequently than reduced/ablated eye phenotype in eyϾCHMP2B Intron5 flies ( Table 1) . Expression of untagged CHMP2B
Intron5 also showed phenotypes similar to Flag-CHMP2B Intron5 (Supplemental Fig. S1 and Table 1 ). ey-Gal4-mediated ectopic expression of CHMP2B WT (Fig. 1E, E=) or CG4618 (Drosophila homologue of CHMP2B; Fig. 1F , F =) showed no obvious defects in eye morphology. eyϾCHMP2B
Intron5 flies also showed a significantly lower adult eclosion rate (i.e., higher mortality) before adulthood relative to wild-type and eyϾ CHMP2B
WT flies (wild-type, 94Ϯ1.0%; eyϾCHMP2B WT , 92Ϯ1.6%; eyϾCHMP2B Intron5 , 76Ϯ5.4%, ANOVA, Scheffé, P Ͻ 0.01). We previously demonstrated that UAS-CHMP2B Intron5 and UAS-CHMP2B WT transgenes had comparable expression levels by GMR-Gal4 (11) . However, ey-Gal4 driver revealed variations in the expression levels of the transgenes. Flag-CHMP2B
Intron5 showed more robust expression than UAS-CHMP2B
Intron5 and UAS-CHMP2B
WT (Supplemental Fig. S2 ). Taken together, these findings indicate that CHMP2B Intron5 causes eye deformities.
We further characterized the structural and functional aspects of the eyϾCHMP2B Intron5 phenotype. Lon- 
WT (E, E =) or eyϾCG4618 (fly homologue of CHMP2B; F, F =) contained no remarkable defects in eye morphology. gitudinal sections of the wild-type eyes showed normal curvature of the eye ( Fig. 2A) and precise arrangement of the photoreceptor cell nuclei in the retina (Fig.  2A=) . eyϾCHMP2B Intron5 flies showed defects in the eye curvature (Fig. 2B) and patterning of the photoreceptor cell nuclei (Fig. 2B =) . However, the enlarged eye with additional eye units (ommatidia) appeared to contain normal photoreceptor cells, as indicated by a comparable rhodopsin localization pattern and content in eyϾCHMP2B
Intron5 flies to wild-type flies (Fig. 2AЉ, BЉ,  D) . Furthermore, the eyϾCHMP2B
Intron5 retina appeared better than that of the GMRϾCHMP2B Intron5 retina, which showed retinal degeneration due to defects in the depth of the retinal layer (Fig. 2C ) and the density of photoreceptor cell nuclei (Fig. 2C=) as well as reduced rhodopsin content (Fig. 2CЉ, D) .
To determine whether CHMP2B Intron5 -mediated structural defects in the eye were associated with physiological defects, we conducted a countercurrent distribution phototactic assay (25) . Consistent with previous studies, wild-type flies showed a strong preference for light, with 96% favoring the illuminated end of the apparatus Ն2 times in 3 trials (25) . GMRϾCHMP2B Intron5 flies, which showed retinal degeneration, showed severe defects in phototactic index (19%). eyϾ CHMP2B Intron5 flies showed significant defects in phototactic behavior relative to wild-type and eyϾCHMP2B WT flies ( Fig. 2E ; wild-type, 94%; eyϾCHMP2B WT , 81%; Intron5 showed no perturbation of the eye curvature, but did show defects in the depth of the retinal layer (C), density of photoreceptor cell nuclei (C =), and reduced rhodopsin level (C Љ, D), indicating retinal degeneration. Western blots were probed using anti-Flag antibody (for Flag-CHMP2B Intron5 ). ninaE I18 (Rh1 rhodopsin null) was used as a negative control for rhodopsin blot, and tubulin was used as the loading control. E) Phototactic assay of wild-type (CS) and eyϾCHMP2B
WT flies showed a strong preference for light (96 and 46% of flies making at least 2/3 light decisions, respectively). eyϾCHMP2B
Intron5 and GMRϾCHMP2B Intron5 flies showed significant defect in preference for the illuminated end of the apparatus, indicating defective phototactic behavior. Columns represent means Ϯ sem of 3-6 independent replicates. *P Ͻ 0.05, ***P Ͻ 0.001; ANOVA, post hoc Scheffe. , 46%, ANOVA, Scheffé P Ͻ 0.001). Therefore, these findings demonstrate that CHMP2B Intron5 expression results in structural and physiological defects in the eyes (Figs. 1 and 2 ).
CHMP2B
Intron5 causes accumulation of Notch in endosomes and elevated signaling
The eyϾCHMP2B
Intron5 eye phenotype was similar to the eye tumorigenesis observed in ey-Gal4 driven constitutive active Notch (eyϾN act ; ref. 26 ) and flies with mutations in ESCRT-I (vps23/erupted/tsg101, vps28), ESCRT-II (vps22 and vps25) and ESCRT-III (vps2 and vps20) components due to Notch accumulation (27) (28) (29) (30) (31) (32) . Therefore, we investigated whether eye deformities in eyϾCHMP2B
Intron5 flies was due to Notch up-regulation. We found that Notch level was significantly elevated in eyϾCHMP2B
Intron5 heads relative to wild-type heads (Fig. 3A, B) .
Immunolocalization in longitudinal sections of eyϾ CHMP2B
Intron5 eyes revealed accumulation of Notch in enlarged punctae relative to eyϾCHMP2B WT eyes (Fig. 4) . To determine the vesicular identity of the enlarged Notch punctae, we colocalized Notch with Rab5 and Rab7 as markers of early endosomes and late endosomes/MVBs respectively (32) (33) (34) (35) . eyϾCHMP2B
Intron5 eyes showed enlarged Rab5 and Rab7 positive endosomes, which showed partial colocalization with Notch positive puncta relative to eyϾCHMP2B WT eyes (Fig. 4) . We next investigated whether the buildup of Notch in endosomes results in up-regulation of Notch signaling, which eventually leads to activation of genes containing Notch response element (NRE) in their promoter (36, 37) . To accomplish this, we utilized transgenic flies containing NRE upstream of the eGFP open reading frame (36) . Flies expressing eyϾ CHMP2B Intron5 in the NRE-GFP background showed significantly elevated eGFP transcription when compared to sibling controls containing only the NRE-GFP element (Fig. 5A) .
To determine whether elevation in Notch signaling is influenced by changes in repressors of Notch in eyϾCHMP2B
Intron5 flies, we tested the levels of Numb, a negative regulator of Notch signaling (38) . Numb level in eyϾCHMP2B
Intron5 flies did not appear to differ significantly from levels in wild-type and eyϾCHMP2B WT flies (Fig. 5B) . Overall, these findings indicate that CHMP2B
Intron5 expression results in Notch accumulation in enlarged endosomes and elevated signaling.
Notch heterozygosity rescues ey>CHMP2B
Intron5 eye deformities and phototactic defects To examine the relative contribution of Notch activation in the eyϾCHMP2B
Intron5 eye phenotype, we expressed CHMP2B
Intron5 with ey-Gal4 in a reduced Notch gene dose background, i.e., the Notch (N 264-39 ) heterozygote. N ; eyϾCHMP2B Intron5 flies showed remarkable recovery from eye deformities (Fig. 6A-C) , eye curvature (Fig. 6A=-C =) , patterning of the photoreceptor nuclei layer (Fig. 6AЉ-CЉ) , and phototactic behavior (Fig.  6D ). These findings demonstrate that eyϾCHMP2B
Intron5 eye phenotypes are primarily due to Notch up-regulation. 
DISCUSSION
CHMP2B
Intron5 mutation, originally identified in a Danish kindred with FTD associated with chromosome 3 (FTD-3; ref. 6) , is a gain-of-function mutation that disrupts the endosomal-lysosomal pathway, resulting in accumulation of cell membrane receptors in cell culture and mouse models of FTD-3 (14, 15) . We previously demonstrated that GMR-Gal4 driven ectopic expression of CHMP2B Intron5 caused melanization due to misregulation of the Toll receptor-signaling pathway in Drosophila eye (11) . Drosophila eye development is a well-studied developmental process in which multiple signaling pathways including the Notch receptor play key roles (39) . Here, we demonstrated that ectopic expression of CHMP2B Intron5 using eyelessGal4 (eyϾCHMP2B Intron5 ) caused changes in eye ranging from severe deformities and enlargement to ablation. ESCRT mutants were previously shown to have enlarged or smaller than normal eye disc sizes (28, 40) . Although Flag-tagged CHMP2B Intron5 showed higher expression level than the untagged CHMP2B Intron5 , their comparable eye phenotypes indicated the N-terminal Flag tag has no remarkable effect. In addition,
eyϾCHMP2B
WT flies showed no apparent phenotype. Lack of a phenotype in eyϾCHMP2B WT flies could be partially caused by a significantly lower expression levels relative to eyϾCHMP2B Intron5 flies. However, using GMR-Gal4, we previously demonstrated that GMRϾ CHMP2B
WT flies had a mild phenotype relative to severe melanotic phenotype in GMRϾCHMP2B Intron5 eyes, despite comparable expression levels (11). The differences in eye phenotypes between ey-Gal4 and GMR-Gal4 driven expression of CHMP2B Intron5 were likely due to differential spatiotemporal expression by the GMR-and ey-Gal4 drivers. Previously, ey-Gal4 and GMR-Gal4 driven expression of a transgene were also shown to have different phenotypes (26) . Specifically, expression of constitutively active Notch using ey-Gal4 (eyϾN act ) caused severe eye hyperplasia, while only a mild phenotype was observed with GMR-Gal4 (26) . The morphological and functional defects in eyϾCHMP2B
Intron5 flies were associated with accumulation of Notch levels and up-regulation of Notch-mediated signaling. Moreover, eyϾCHMP2B
Intron5 eyes in Notch heterozygous background showed robust improvement of deformities and phototactic defects. The eyϾCHMP2B Intron5 eye phenotype was similar to the eye tumorigenesis observed due to ectopic expression of constitutively active Notch in eyϾN act flies (26) and Notch accumulation in response to mutations in ESCRT-I (vps23/erupted/tsg101, vps28), ESCRT-II (vps22 and vps25), and ESCRT-III (vps2 and vps20) components (27) (28) (29) (30) (31) (32) . In addition, Notch is a wellcharacterized positive regulator of eye disc proliferation during eye development (42, 43) .
Cell surface receptors such as Notch normally initiate signaling on ligand binding when embedded in the plasma membrane. Incorporation of receptors into endosomes is generally considered a mechanism that limits signaling of receptors by negating their access to extracellular ligands. However, Notch signaling has been shown to persist when Notch is located in the abnormally enlarged endocytic vesicles in ESCRT mutants (44, 45) . Previous studies with ESCRT component mutants (e.g., vps23 and vps25), mostly using ESCRT component mutant mosaics generated in the eyeless expression pattern (ey-FLP system), showed Notch misregulation-associated overproliferation in both normal (nonautonomous) and mutant cells (autonomous) followed by apoptosis in only mutant cells (27-30, 40, 46) . A recent study of ESCRT-II mutants using eye disc mosaics containing predominantly mutant cells revealed autonomous neoplastic proliferation followed by apoptosis and mortality before adulthood (40) . In this study, we used the ey-Gal4-UAS expression paradigm; therefore, all eye disc cells expressed CHMP2B Intron5 prior to differentiation into photoreceptor cells because of the ey-Gal4 expression pattern (21) . eyϾ CHMP2B Intron5 flies showed substantial mortality before adulthood, and enlarged eye phenotype was more frequent than ablated eye phenotype in the surviving adults. Therefore, the pathway mediating enlargement may have been stronger than the pathway mediating early mortality and ablation in eyϾCHMP2B
Intron5 flies that survived to adulthood.
In summary, our findings support the notion that CHMP2B Intron5 mutation disrupts the endosomal-lysosomal pathway, resulting in accumulation of cell membrane receptors. Depending on the spatiotemporal attributes of CHMP2B Intron5 expression, different receptors and their signaling are predominantly misregulated. Similar to ESCRT mutants, CHMP2B
Intron5 -mediated blockage of the endosomal-lysosomal pathway may lead to the buildup of many transmembrane proteins (27, 29, 30, 46) . Interestingly, tumorigenic phenotype was not observed in affected individuals of the Danish kindred with CHMP2B Intron5 mutation (7) (8) (9) . A mouse model of CHMP2B
Intron5 also showed no remarkable cell overproliferation (14) . Nevertheless, the results of the present study contribute to the overall understanding of how molecular and cellular defects can manifest in the presence of CHMP2B
Intron5 . Here and in our previous study (11) , we focused on the most prominent phenotype due to CHMP2B
Intron5 expression in fly eyes, which primarily occurs as a result of misregulation of one receptor and its signaling pathway. The strongest phenotype can likely be attributed to the most active receptor and/or the most sensitive receptor to misregulation during CHMP2B Intron5 expression. It will be interesting to identify additional receptors misregu- lated by CHMP2B
Intron5 in eyes and central nervous system neurons.
